Bank of Nova Scotia’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $4.38M | Sell |
8,327
-2,797
| -25% | -$1.57M | 0.01% | 642 |
|
|
2026
Q1 | $6.25M | Sell |
11,124
-1,383
| -11% | -$887K | 0.01% | 534 |
|
|
2025
Q4 | $8.46M | Buy |
12,507
+2,636
| +27% | +$1.8M | 0.01% | 523 |
|
|
2025
Q3 | $6.31M | Sell |
9,871
-18,464
| -65% | -$11.2M | 0.01% | 502 |
|
|
2025
Q2 | $15.2M | Sell |
28,335
-58,692
| -67% | -$28.1M | 0.03% | 303 |
|
|
2025
Q1 | $36.5M | Buy |
87,027
+62,938
| +261% | +$27.3M | 0.08% | 185 |
|
|
2024
Q4 | $9.96M | Buy |
24,089
+14,307
| +146% | +$6.28M | 0.02% | 417 |
|
|
2024
Q3 | $4.94M | Buy |
9,782
+1,857
| +23% | +$902K | 0.01% | 471 |
|
|
2024
Q2 | $3.86M | Sell |
7,925
-19,811
| -71% | -$9.95M | 0.01% | 511 |
|
|
2024
Q1 | $15M | Buy |
27,736
+275
| +1% | +$150K | 0.03% | 326 |
|
|
2023
Q4 | $15.2M | Buy |
27,461
+19,821
| +259% | +$9.31M | 0.03% | 342 |
|
|
2023
Q3 | $3.34M | Buy |
7,640
+1,357
| +22% | +$677K | 0.01% | 487 |
|
|
2023
Q2 | $3.16M | Sell |
6,283
-33,859
| -84% | -$16.2M | 0.01% | 438 |
|
|
2023
Q1 | $20.1M | Sell |
40,142
-38,915
| -49% | -$18.6M | 0.06% | 200 |
|
|
2022
Q4 | $32.3M | Buy |
79,057
+72,162
| +1,047% | +$28M | 0.08% | 179 |
|
|
2022
Q3 | $2.25M | Sell |
6,895
-71
| -1% | -$26.1K | 0.01% | 602 |
|
|
2022
Q2 | $2.44M | Sell |
6,966
-3,556
| -34% | -$1.45M | 0.01% | 646 |
|
|
2022
Q1 | $5.76M | Sell |
10,522
-8,665
| -45% | -$4.56M | 0.01% | 567 |
|
|
2021
Q4 | $12.6M | Buy |
19,187
+2,178
| +13% | +$1.37M | 0.02% | 477 |
|
|
2021
Q3 | $10.6M | Sell |
17,009
-1,803
| -10% | -$1.21M | 0.02% | 466 |
|
|
2021
Q2 | $11.9M | Sell |
18,812
-3,211
| -15% | -$1.77M | 0.02% | 410 |
|
|
2021
Q1 | $10.8M | Sell |
22,023
-39,680
| -64% | -$19.9M | 0.02% | 384 |
|
|
2020
Q4 | $30.8M | Sell |
61,703
-58,923
| -49% | -$26.4M | 0.07% | 233 |
|
|
2020
Q3 | $47.4M | Buy |
120,626
+110,070
| +1,043% | +$40.7M | 0.13% | 148 |
|
|
2020
Q2 | $3.48M | Sell |
10,556
-16,181
| -61% | -$4.69M | 0.01% | 476 |
|
|
2020
Q1 | $6.48M | Sell |
26,737
-74,373
| -74% | -$19.4M | 0.02% | 377 |
|
|
2019
Q4 | $26.4M | Buy |
101,110
+59,359
| +142% | +$15.6M | 0.06% | 237 |
|
|
2019
Q3 | $11.4M | Buy |
41,751
+20,106
| +93% | +$5.59M | 0.03% | 351 |
|
|
2019
Q2 | $5.96M | Sell |
21,645
-4,747
| -18% | -$1.17M | 0.03% | 384 |
|
|
2019
Q1 | $5.9M | Buy |
26,392
+7,916
| +43% | +$1.63M | 0.02% | 401 |
|
|
2018
Q4 | $3.44M | Buy |
18,476
+849
| +5% | +$174K | 0.02% | 480 |
|
|
2018
Q3 | $4.4M | Buy |
17,627
+8,148
| +86% | +$1.98M | 0.02% | 454 |
|
|
2018
Q2 | $2.07M | Sell |
9,479
-1,632
| -15% | -$336K | 0.01% | 492 |
|
|
2018
Q1 | $2.13M | Sell |
11,111
-9,753
| -47% | -$1.8M | 0.01% | 550 |
|
|
2017
Q4 | $3.26M | Sell |
20,864
-15,838
| -43% | -$2.49M | 0.01% | 485 |
|
|
2017
Q3 | $5.71M | Buy |
36,702
+9,522
| +35% | +$1.51M | 0.03% | 346 |
|
|
2017
Q2 | $4.39M | Sell |
27,180
-2,349
| -8% | -$381K | 0.02% | 444 |
|
|
2017
Q1 | $4.57M | Buy |
29,529
+20,129
| +214% | +$2.77M | 0.02% | 427 |
|
|
2016
Q4 | $1.1M | Hold |
9,400
| – | – | 0.01% | 468 |
|
|
2016
Q3 | $1.06M | Hold |
9,400
| – | – | 0.01% | 386 |
|
|
2016
Q2 | $873K | Hold |
9,400
| – | – | 0.01% | 390 |
|
|
2016
Q1 | $736K | Hold |
9,400
| – | – | ﹤0.01% | 406 |
|
|
2015
Q4 | $685K | Hold |
9,400
| – | – | ﹤0.01% | 453 |
|
|
2015
Q3 | $698K | Buy |
9,400
+4,200
| +81% | +$301K | ﹤0.01% | 363 |
|
|
2015
Q2 | $333K | Buy |
5,200
+200
| +4% | +$13.8K | ﹤0.01% | 455 |
|
|
2015
Q1 | $386K | Buy |
5,000
+2,000
| +67% | +$156K | ﹤0.01% | 418 |
|
|
2014
Q4 | $222K | Buy |
+3,000
| New | +$210K | ﹤0.01% | 522 |
|
|
2014
Q3 | – | Sell |
-3,000
| Closed | -$200K | – | 574 |
|
|
2014
Q2 | $200K | Buy |
+3,000
| New | +$191K | ﹤0.01% | 544 |
|
Other funds holding IDXX
Bank of Nova Scotia's IDXX Position: Q2 2026 in Review
Bank of Nova Scotia reduced its Idexx Laboratories (IDXX) stake by 25% in Q2 2026, selling an estimated $1.57M and leaving 8,327 shares worth $4.38M. The position accounts for 0.01% of the portfolio, ranked #642.
Bank of Nova Scotia first reported a position in IDXX in Q2 2014 and has held it in 48 quarters since. The position peaked at $47.4M in Q3 2020. 1,295 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.
- Bank of Nova Scotia held 8,327 shares of Idexx Laboratories worth $4.38M as of Q2 2026.
- Bank of Nova Scotia sold 2,797 Idexx Laboratories shares in Q2 2026, an estimated $1.57M.
- Idexx Laboratories made up 0.01% of Bank of Nova Scotia's portfolio in Q2 2026, its #642 holding.
- Bank of Nova Scotia first reported a position in Idexx Laboratories in Q2 2014 and has held it in 48 quarters since.
- Bank of Nova Scotia's Idexx Laboratories position peaked at $47.4M in Q3 2020.
- 1,295 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.
Based on Bank of Nova Scotia's 13F filing for Q2 2026, filed 12 Aug 2026.